Insider Buying: Crescent Capital BDC, Inc. (NASDAQ:CCAP) CEO Purchases 2,800 Shares of Stock

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Rating) CEO Jason Breaux bought 2,800 shares of Crescent Capital BDC stock in a transaction on Thursday, May 12th. The shares were purchased at an average cost of $17.09 per share, for a total transaction of $47,852.00. Following the completion of the purchase, the chief executive officer now directly owns 41,592 shares of the company’s stock, valued at $710,807.28. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of Crescent Capital BDC stock opened at $17.01 on Friday. The company has a fifty day simple moving average of $17.69 and a 200-day simple moving average of $18.15. Crescent Capital BDC, Inc. has a 12-month low of $16.58 and a 12-month high of $21.48. The company has a current ratio of 0.80, a quick ratio of 1.37 and a debt-to-equity ratio of 0.96. The stock has a market cap of $525.44 million, a price-to-earnings ratio of 6.30, a PEG ratio of 0.85 and a beta of 0.88.

Crescent Capital BDC (NASDAQ:CCAPGet Rating) last issued its earnings results on Wednesday, February 23rd. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. Crescent Capital BDC had a net margin of 78.46% and a return on equity of 7.88%. The business had revenue of $24.14 million during the quarter, compared to analysts’ expectations of $24.24 million. On average, analysts forecast that Crescent Capital BDC, Inc. will post 1.66 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 15th. Investors of record on Thursday, June 30th will be given a $0.41 dividend. The ex-dividend date of this dividend is Wednesday, June 29th. This represents a $1.64 annualized dividend and a yield of 9.64%. Crescent Capital BDC’s dividend payout ratio (DPR) is 60.74%.

A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Tuesday, April 26th. Bank of America assumed coverage on shares of Crescent Capital BDC in a research note on Monday, January 31st. They issued a “buy” rating and a $19.50 price target on the stock. Finally, Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating on the stock in a research note on Monday, April 25th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Crescent Capital BDC has an average rating of “Hold” and an average price target of $19.70.

A number of hedge funds have recently added to or reduced their stakes in CCAP. Captrust Financial Advisors purchased a new position in Crescent Capital BDC during the 3rd quarter worth $103,000. JPMorgan Chase & Co. purchased a new position in Crescent Capital BDC during the 1st quarter worth $185,000. LPL Financial LLC purchased a new position in Crescent Capital BDC during the 4th quarter worth $190,000. Comerica Bank purchased a new position in Crescent Capital BDC during the 3rd quarter worth $215,000. Finally, Eagle Global Advisors LLC purchased a new position in Crescent Capital BDC during the 4th quarter worth $222,000. Hedge funds and other institutional investors own 54.76% of the company’s stock.

Crescent Capital BDC Company Profile (Get Rating)

Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.

Featured Articles

Insider Buying and Selling by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.